NO922506D0 - Farmasoeytiske preparat - Google Patents

Farmasoeytiske preparat

Info

Publication number
NO922506D0
NO922506D0 NO922506A NO922506A NO922506D0 NO 922506 D0 NO922506 D0 NO 922506D0 NO 922506 A NO922506 A NO 922506A NO 922506 A NO922506 A NO 922506A NO 922506 D0 NO922506 D0 NO 922506D0
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
NO922506A
Other languages
English (en)
Other versions
NO303964B1 (no
NO922506L (no
Inventor
Birgit Hauer
Armin Meinzer
Ulrich Posanski
Jacky Vonderscher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922506(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO922506D0 publication Critical patent/NO922506D0/no
Publication of NO922506L publication Critical patent/NO922506L/no
Publication of NO303964B1 publication Critical patent/NO303964B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
NO922506A 1991-06-27 1992-06-25 Farmasöytiske preparat NO303964B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
NO922506D0 true NO922506D0 (no) 1992-06-25
NO922506L NO922506L (no) 1992-12-28
NO303964B1 NO303964B1 (no) 1998-10-05

Family

ID=10697415

Family Applications (2)

Application Number Title Priority Date Filing Date
NO922506A NO303964B1 (no) 1991-06-27 1992-06-25 Farmasöytiske preparat
NO19964382A NO325267B1 (no) 1991-06-27 1996-10-15 Transforestringsprodukt av maisolje og glycerol, fremgangsmate for fremstilling derav og anvendelser av transforestringsproduktet

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO19964382A NO325267B1 (no) 1991-06-27 1996-10-15 Transforestringsprodukt av maisolje og glycerol, fremgangsmate for fremstilling derav og anvendelser av transforestringsproduktet

Country Status (38)

Country Link
EP (2) EP0953630B1 (no)
JP (2) JP2653958B2 (no)
KR (3) KR0131064B1 (no)
CN (1) CN1077798C (no)
AT (1) AT403436B (no)
AU (1) AU659460B2 (no)
CA (2) CA2175842C (no)
CH (2) CH684163A5 (no)
CY (1) CY1906A (no)
CZ (1) CZ281790B6 (no)
DE (3) DE4219526C2 (no)
DK (2) DK0953630T3 (no)
EE (1) EE03108B1 (no)
ES (2) ES2142818T3 (no)
FI (2) FI109454B (no)
FR (2) FR2678169B1 (no)
GB (2) GB9113872D0 (no)
GR (1) GR3032366T3 (no)
HK (2) HK57196A (no)
HU (1) HU216792B (no)
IE (1) IE73662B1 (no)
IL (3) IL102310A (no)
IT (1) IT1254401B (no)
LU (1) LU88138A1 (no)
MX (1) MX9203236A (no)
MY (1) MY109512A (no)
NO (2) NO303964B1 (no)
NZ (1) NZ243309A (no)
PH (1) PH30337A (no)
PT (2) PT953630E (no)
RO (2) RO111021B1 (no)
RU (1) RU2143919C1 (no)
SA (1) SA92130213B1 (no)
SK (1) SK278759B6 (no)
TW (1) TW267943B (no)
UA (1) UA35559C2 (no)
UY (1) UY23864A1 (no)
ZA (1) ZA924719B (no)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
DK0589843T3 (da) * 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
ES2308955T5 (es) 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
EP0694308A4 (en) * 1994-02-17 1997-09-10 Shiseido Co Ltd CYCLOSPORIN EMULSION COMPOSITION
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
DE69510404T2 (de) * 1994-03-31 2000-01-20 Loders Croklaan Bv Öle mit niedrigem Gehalt an gesättigter Fettsäure
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
PT789580E (pt) 1994-11-03 2002-09-30 Novartis Ag Formulacoes de ciclosporina para administracao oral com composicao simples e alta biodisponibilidade e processo para a sua producao
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
CA2220451A1 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Methods and compositions for improving digestion and absorption in the small intestine
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
SI9720010B (sl) * 1996-06-19 2009-10-31 Novartis Ag Ciklosporin vsebujoči mehki kapsulni pripravki
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6517860B1 (en) 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
CZ301382B6 (cs) * 1997-03-12 2010-02-10 Abbott Laboratories Chad377/Ap6D-2 Hydrofilní binární systémy pro podávání cyklosporinu
CA2285983A1 (en) 1997-04-29 1998-11-05 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
WO1999006024A1 (en) * 1997-07-29 1999-02-11 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
AU728695B2 (en) * 1997-07-29 2001-01-18 Boehringer Ingelheim International Gmbh Self-emulsifying formulation for lipophilic compounds
JP4524367B2 (ja) 1997-07-29 2010-08-18 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 自己乳化性処方形態の酸性親油性化合物用の医薬組成物
CA2306448A1 (en) 1997-10-16 1999-04-22 Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
AU1508899A (en) * 1997-12-02 1999-06-16 Chong Kun Dang Corporation Pharmaceutical composition comprising cyclosporin solid-state microemulsion
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
ATE262916T1 (de) * 1998-08-18 2004-04-15 Panacea Biotec Ltd Zusammensetzung enthalten cyclsoporin in einem hydrophilen träger
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
US7008661B2 (en) 2000-08-08 2006-03-07 Kao Corporation Oil/fat composition
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
JP4261355B2 (ja) 2001-10-19 2009-04-30 アイソテクニカ インコーポレイテッド シクロスポリン類似体の合成法
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
JP2010523554A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
EP2464341B1 (en) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) * 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FI65914C (fi) * 1978-03-07 1984-08-10 Sandoz Ag Foerfarande foer framstaellning av farmaceutiska kompositionerinnehaollande cyklosporin a
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
PH19156A (en) * 1982-02-01 1986-01-15 Sandoz Ltd Dihydrocyclosporin d in the treatment of multiple sclerosis
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (no) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
GB2230440B (en) * 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
DE4219526A1 (de) 1993-03-18
RU2143919C1 (ru) 2000-01-10
EP0539319A2 (en) 1993-04-28
FI961513A0 (fi) 1996-04-03
CZ281790B6 (cs) 1997-01-15
FR2685706B1 (no) 1994-12-23
PT539319E (pt) 2000-05-31
HU216792B (hu) 1999-08-30
CY1906A (en) 1992-06-24
HUT62201A (en) 1993-04-28
NO964382D0 (no) 1996-10-15
JPH05186365A (ja) 1993-07-27
FR2678169B1 (fr) 1994-08-26
CN1077798C (zh) 2002-01-16
DE4244930C2 (de) 1999-11-11
IL118546A (en) 1998-09-24
LU88138A1 (fr) 1994-03-01
TW267943B (no) 1996-01-11
GB2257359A (en) 1993-01-13
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
RO111110B1 (ro) 1996-06-28
DE4244986B4 (de) 2008-07-24
NZ243309A (en) 1995-02-24
GR3032366T3 (en) 2000-04-27
SK197792A3 (en) 1994-03-09
AU659460B2 (en) 1995-05-18
GB2257359B (en) 1996-01-10
PT953630E (pt) 2004-11-30
FI109454B (fi) 2002-08-15
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
ITRM920476A1 (it) 1993-12-23
CN1079907A (zh) 1993-12-29
NO325267B1 (no) 2008-03-17
EE03108B1 (et) 1998-08-17
ZA924719B (en) 1993-12-27
EP0539319A3 (en) 1993-06-09
IL102310A0 (en) 1993-01-14
GB9213393D0 (en) 1992-08-05
FI922958A0 (fi) 1992-06-25
HK157696A (en) 1996-08-30
FI961513A (fi) 1996-04-03
AT403436B (de) 1998-02-25
GB9113872D0 (en) 1991-08-14
HU9201975D0 (en) 1992-09-28
PH30337A (en) 1997-04-02
ES2142818T3 (es) 2000-05-01
KR930000113A (ko) 1993-01-15
FR2685706A1 (fr) 1993-07-02
EP0953630A1 (en) 1999-11-03
ATA129892A (de) 1997-07-15
IL102310A (en) 1997-03-18
UY23864A1 (es) 1995-05-29
CA2175842C (en) 2002-05-07
RO111021B1 (ro) 1996-06-28
KR0131064B1 (ko) 1998-04-17
FI922958A (fi) 1992-12-28
NO964382L (no) 1992-12-28
CA2175842A1 (en) 1992-12-28
DK0953630T3 (da) 2004-11-01
ES2227921T3 (es) 2005-04-01
IL118546A0 (en) 1996-10-16
FR2678169A1 (fr) 1992-12-31
HK57196A (en) 1996-04-12
IT1254401B (it) 1995-09-14
NO303964B1 (no) 1998-10-05
CZ197792A3 (en) 1993-01-13
IE73662B1 (en) 1997-06-18
CA2072509A1 (en) 1992-12-28
JP2653958B2 (ja) 1997-09-17
AU1852792A (en) 1993-03-11
DK0539319T3 (da) 2000-05-22
CH685764A5 (de) 1995-09-29
DE4219526C2 (de) 1999-04-22
SK278759B6 (sk) 1998-02-04
EP0539319B1 (en) 1999-12-08
KR100231384B1 (en) 1999-11-15
CH684163A5 (de) 1994-07-29
FI116199B (fi) 2005-10-14
KR100231385B1 (en) 1999-11-15
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
JP3420897B2 (ja) 2003-06-30
CA2072509C (en) 1996-07-30
EP0953630B1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
NO922506L (no) Farmasoeytiske preparat
NO921958L (no) Farmasoeytisk preparat
NO922006D0 (no) Farmasoeytisk preparat
NO943888D0 (no) Farmasöytisk preparat
FI921060A (fi) Farmaceutiska aerosolformuleringar
DK0585252T3 (da) Farmaceutiske formuleringer
FI923581A (fi) Farmaceutisk kombinationsformation
DE69224656D1 (de) Arzneimittel
NO954146D0 (no) Belagte farmasöytiske preparater
NO962694D0 (no) Percutant farmasöytisk preparat
NO923859D0 (no) Medikament
FI930882A0 (fi) Farmaceutiska foereningar
DK19991D0 (da) Proteinpraeparationer
FI922743A (fi) Preparat
NO931014D0 (no) Farmasoeytisk preparat
NO921691D0 (no) Farmasoeytisk preparat
NO920564L (no) Farmasoeytiske adenosinholdige preparater
DK75791D0 (da) Novel pharmaceutical preparations
NO964775D0 (no) Fast farmasöytisk adenosinholdig preparat
NO920039D0 (no) Farmasoeytiske preparater
NO920647L (no) Nasalt farmasoeytisk preparat
DK206691D0 (da) Agrochemical preparations
DK204691D0 (da) Hidtil ukendt farmaceutisk praeparat
SE9302430D0 (sv) Nwe pharmaceutical preparation
SE9302429D0 (sv) New pharmaceutical preparation ii

Legal Events

Date Code Title Description
MK1K Patent expired